{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T08:59:49Z","timestamp":1791622789568,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Threatened preterm delivery (TPD) is the leading cause of inpatient admissions during pregnancy. The ability to predict the risk of imminent preterm delivery is thus a major priority in obstetrics. The aim of our study is to assess the diagnostic performance of the test to detect the placental alpha microglobulin 1 (PAMG-1) for the prediction of delivery within 7 days in women with TPD.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>This is a prospective multicenter diagnostic study. Inclusion criteria are singleton pregnancy, gestational age between 24\u2009+\u20090 and 33\u2009+\u20096 weeks inclusive, cervical measurement 25\u00a0mm or less assessed by transvaginal ultrasound (with or without uterine contractions), clinically intact membranes and cervical dilatation\u2009&lt;\u20093\u00a0cm assessed by digital examination.<\/jats:p>\n<jats:p>According to the current protocol, when a women presents with TPD and the diagnosis is confirmed by transvaginal ultrasound, a vaginal sample to test for genital infection is performed. At the same time, the midwife will perform the PartoSure\u00ae test. To perform this analysis, a sample of cervicovaginal secretions is taken with the vaginal swab furnished in the test kit.<\/jats:p>\n<jats:p>The primary outcome is the specificity of the PartoSure\u00ae test of women who gave birth more than 7 days after their hospitalization for TPD. The secondary outcomes are the sensitivity, PPV, and NPV of the Partosure\u00ae test and the factors associated with false positives (with a univariate logistic regression model).<\/jats:p>\n<jats:p>Starting with the hypothesis of an anticipated specificity of 89%, if we want to estimate this specificity with a confidence interval of \u00b1 5%, we will require 151 women who do not give birth within 7 days. We therefore decided to include 400 women over a period of two years to have a larger number of events (deliveries within 7 days).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Discussion<\/jats:title>\n<jats:p>The different tests already used such as fetal fibronectin and phIGFBP-1, are not sufficiently relevant to recommend their use in daily practice. The different studies of PAMG-1 described above thus provide support for the use of this substance, tested by PartoSure\u00ae. Nonetheless, other larger studies are necessary to validate its use in daily practice and our study could answer this question.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Trial registration<\/jats:title>\n<jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03401255?term=NCT03401255&amp;draw=2&amp;rank=1\">NCT03401255<\/jats:ext-link> (January 15, 2018)<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12884-020-03129-x","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T10:05:39Z","timestamp":1596449139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The value of a vaginal sample for detecting PAMG-1 (Partosure\u00ae) in women with a threatened preterm delivery (the MAPOSURE Study): protocol for a multicenter prospective study"],"prefix":"10.1186","volume":"20","author":[{"given":"Emilie","family":"Marie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Ducarme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Boivin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Badon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Pelerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Le Thuaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeineb","family":"Lamoureux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9ry-Pierre","family":"Riche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Winer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Thubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Dochez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,3]]},"reference":[{"key":"3129_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ejogrb.2016.12.035","volume":"210","author":"L Sentilhes","year":"2016","unstructured":"Sentilhes L, S\u00e9nat M-V, Ancel P-Y, Azria E, Benoist G, Blanc J, et al. Prevention of spontaneous preterm birth: Guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF). Eur J Obstet Gynecol Reprod Biol. 2016;210:217\u201324.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3129_CR2","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. - Mesure de la longueur du canal cervical du col de l\u2019ut\u00e9rus par \u00e9chographie par voie vaginale: Int\u00e9r\u00eat dans la pr\u00e9vision de l\u2019accouchement pr\u00e9matur\u00e9 spontan\u00e9. Rapport d\u2019\u00e9valuation technologique. Juillet 2010. http:\/\/www.has-sante.fr\/portail\/jcms\/c_894981\/fr\/mesure-de-la-longueur-du-canal-cervical-du-col-de-l-uterus-par-echographie-par-voie-vaginale-interet-dans-la-prevision-de-l-accouchement-premature-spontane. Accessed 22 Jan 2017."},{"key":"3129_CR3","unstructured":"Enqu\u00eate nationale p\u00e9rinatale - Rapport. 2016. https:\/\/drees.solidarites-sante.gouv.fr\/IMG\/pdf\/synthese-enp2017.pdf."},{"key":"3129_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0029-7844(98)00108-2","volume":"92","author":"W Hueston","year":"1998","unstructured":"Hueston W. Preterm Contractions in Community Settings: II. Predicting Preterm Birth in Women With Preterm Contractions. Obstet Gynecol. 1998;92:43\u20136.","journal-title":"Obstet Gynecol"},{"key":"3129_CR5","doi-asserted-by":"crossref","unstructured":"Cabrol D, Goffinet F, Carbonne B, Dreyfus M, Ercole C, Ancel P-Y, CNGOF - RECOMMANDATIONS. POUR LA PRATIQUE CLINIQUE. La menace d\u2019accouchement pr\u00e9matur\u00e9 (MAP) \u00e0 membranes intactes. J Gynecol Obstet Biol Reprod. 2002;31 suppl\u00e9ent 7. http:\/\/www.cngof.asso.fr\/D_PAGES\/PURPC_10.HTM. Accessed 21 Jan 2017.","DOI":"10.1016\/S1297-9589(03)00021-3"},{"key":"3129_CR6","unstructured":"Ancel P-Y. Menace d\u2019accouchement pr\u00e9matur\u00e9 et travail pr\u00e9matur\u00e9 \u00e0 membranes intactes: physiopathologie, facteurs de risque et cons\u00e9quences. \/data\/revues\/03682315\/0031SUP7\/10\/. 2008. http:\/\/www.em-consulte.com\/en\/article\/114614#JGYN-11-2002-31-S7-0368-2315-101019-ART3-BIB10. Accessed 5 Mar 2017."},{"issue":"98","key":"3129_CR7","first-page":"709","volume":"2001","author":"American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Assessment of risk factors for preterm birth. Clinical management guidelines for obstetrician-gynecologists. Number 31","year":"2001","unstructured":"American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Assessment of risk factors for preterm birth. Clinical management guidelines for obstetrician-gynecologists. Number 31. Replaces Technical Bulletin number 206, June 1995; Committee Opinion number 172, May 1996; Committee Opinion number 187, September 1997; Committee Opinion number 198, February 1998; and Committee Opinion number 251, January 2001. Obstet Gynecol. 2001;2001(98):709\u201316. .","journal-title":"Obstet Gynecol."},{"key":"3129_CR8","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1097\/AOG.0b013e31825af2f0","volume":"119","author":"American College of Obstetricians and Gynecologists, Committee on Practice Bulletins\u2014Obstetrics","year":"2012","unstructured":"American College of Obstetricians and Gynecologists, Committee on Practice Bulletins\u2014Obstetrics. ACOG practice bulletin no. 127: Management of preterm labor. Obstet Gynecol. 2012;119:1308\u201317.","journal-title":"Obstet Gynecol"},{"key":"3129_CR9","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(12)60820-4","volume":"379","author":"H Blencowe","year":"2012","unstructured":"Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller A-B, Narwal R, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379:2162\u201372.","journal-title":"Lancet"},{"key":"3129_CR10","doi-asserted-by":"crossref","unstructured":"Ward RM, Beachy JC. Neonatal complications following preterm birth. BJOG. 2003;110(Suppl 20):8\u201316.","DOI":"10.1046\/j.1471-0528.2003.00012.x"},{"key":"3129_CR11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.emcgo.2005.09.001","volume":"2","author":"V Castaigne","year":"2005","unstructured":"Castaigne V, Picone O, Frydman R. Accouchement du pr\u00e9matur\u00e9 EMC - Gyn\u00e9cologie-Obst\u00e9trique. 2005;2:354\u201363. .","journal-title":"Accouchement du pr\u00e9matur\u00e9. EMC - Gyn\u00e9cologie-Obst\u00e9trique."},{"key":"3129_CR12","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12884-017-1454-x","volume":"17","author":"MD van Zijl","year":"2017","unstructured":"van Zijl MD, Koullali B, Naaktgeboren CA, Schuit E, Bekedam DJ, Moll E, et al. Pessary or Progesterone to Prevent Preterm delivery in women with short cervical length: the Quadruple P randomised controlled trial. BMC Pregnancy Childbirth. 2017;17:284.","journal-title":"BMC Pregnancy Childbirth"},{"key":"3129_CR13","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/uog.3989","volume":"29","author":"RE Bittar","year":"2007","unstructured":"Bittar RE, da Fonseca EB, de Carvalho MHB, Martinelli S, Zugaib M. Predicting preterm delivery in asymptomatic patients with prior preterm delivery by measurement of cervical length and phosphorylated insulin-like growth factor-binding protein-1. Ultrasound Obstet Gynecol. 2007;29:562\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3129_CR14","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3109\/14767058.2010.496879","volume":"24","author":"M Chandiramani","year":"2011","unstructured":"Chandiramani M, Di Renzo GC, Gottschalk E, Helmer H, Henrich W, Hoesli I, et al. Fetal fibronectin as a predictor of spontaneous preterm birth: a European perspective. J Matern-Fetal Neonatal Med. 2011;24:330\u20136.","journal-title":"J Matern-Fetal Neonatal Med"},{"key":"3129_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/uog.6428","volume":"34","author":"D Paternoster","year":"2009","unstructured":"Paternoster D, Riboni F, Vitulo A, Plebani M, Dell\u2019Avanzo M, Battagliarin G, et al. Phosphorylated insulin-like growth factor binding protein-1 in cervical secretions and sonographic cervical length in the prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol. 2009;34:437\u201340.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3129_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1515\/jpm-2013-0234","volume":"42","author":"T Nikolova","year":"2014","unstructured":"Nikolova T, Bayev O, Nikolova N, Di Renzo GC. Evaluation of a novel placental alpha microglobulin-1 (PAMG-1) test to predict spontaneous preterm delivery. J Perinat Med. 2014;42:473\u20137.","journal-title":"J Perinat Med"},{"key":"3129_CR17","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1515\/jpm-2014-0300","volume":"43","author":"T Nikolova","year":"2015","unstructured":"Nikolova T, Bayev O, Nikolova N, Di Renzo GC. Comparison of a novel test for placental alpha microglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor. J Perinat Med. 2015;43:395\u2013402.","journal-title":"J Perinat Med"},{"key":"3129_CR18","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3109\/14767058.2012.657279","volume":"25","author":"SM Lee","year":"2012","unstructured":"Lee SM, Romero R, Park JW, Kim SM, Park C-W, Korzeniewski SJ, et al. The clinical significance of a positive Amnisure test in women with preterm labor and intact membranes. J Matern-Fetal Neonatal Med. 2012;25:1690\u20138.","journal-title":"J Matern-Fetal Neonatal Med"},{"key":"3129_CR19","doi-asserted-by":"crossref","unstructured":"Crowther CA, McKinlay CJD, Middleton P, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev. 2015;CD003935.","DOI":"10.1002\/14651858.CD003935.pub4"},{"key":"3129_CR20","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/aogs.12014","volume":"91","author":"L Eriksson","year":"2012","unstructured":"Eriksson L, Haglund B, Ewald U, Odlind V, Kieler H. Health consequences of prophylactic exposure to antenatal corticosteroids among children born late preterm or term. Acta Obstet Gynecol Scand. 2012;91:1415\u201321.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"3129_CR21","first-page":"1102","volume":"167","author":"EV Asztalos","year":"2013","unstructured":"Asztalos EV, Murphy KE, Willan AR, Matthews SG, Ohlsson A, Saigal S, et al. Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5). JAMA Pediatr. 2013;167:1102\u201310.","journal-title":"JAMA Pediatr"},{"key":"3129_CR22","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/uog.17388","volume":"49","author":"V Berghella","year":"2017","unstructured":"Berghella V, Palacio M, Ness A, Alfirevic Z, Nicolaides K, Saccone G. Cervical length screening for prevention of preterm birth in singleton pregnancies with threatened preterm labor: A Cochrane systematic review and meta-analysis of randomized controlled trials using individual patient-level data. Ultrasound Obstet Gynecol. 2017;49:322\u20139.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3129_CR23","doi-asserted-by":"publisher","first-page":"i3633","DOI":"10.1136\/bmj.i3633","volume":"354","author":"M Kyrgiou","year":"2016","unstructured":"Kyrgiou M, Athanasiou A, Paraskevaidi M, Mitra A, Kalliala I, Martin-Hirsch P, et al. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ. 2016;354:i3633.","journal-title":"BMJ"},{"key":"3129_CR24","doi-asserted-by":"publisher","first-page":"e0163793","DOI":"10.1371\/journal.pone.0163793","volume":"11","author":"LM Kindinger","year":"2016","unstructured":"Kindinger LM, Kyrgiou M, MacIntyre DA, Cacciatore S, Yulia A, Cook J, et al. Preterm Birth Prevention Post-Conization: A Model of Cervical Length Screening with Targeted Cerclage. PloS One. 2016;11:e0163793.","journal-title":"PloS One"},{"key":"3129_CR25","first-page":"208","volume":"33","author":"RM Ehsanipoor","year":"2016","unstructured":"Ehsanipoor RM, Swank ML, Jwa SC, Wing DA, Tarabulsi G, Blakemore KJ. Placental \u03b1-Microglobulin-1 in Vaginal Secretions of Women with Evidence of Preterm Labor. Am J Perinatol. 2016;33:208\u201313.","journal-title":"Am J Perinatol"},{"key":"3129_CR26","doi-asserted-by":"publisher","first-page":"B2","DOI":"10.1016\/j.ajog.2016.04.027","volume":"215","author":"Feltovich J McIntosh","year":"2016","unstructured":"McIntosh Feltovich J, Berghella H, Manuck V T, Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org. The role of routine cervical length screening in selected high- and low-risk women for preterm birth prevention. Am J Obstet Gynecol. 2016;215:B2-7.","journal-title":"Am J Obstet Gynecol"},{"key":"3129_CR27","first-page":"562","volume":"47","author":"J Joly","year":"2019","unstructured":"Joly J, Ducellier-Azzola G, Branger B, Arthuis C, Winer N, Thubert T, et al. [Validation of the cervical length education and review program in a population of French residents in obstetrics and gynecology]. Gynecol Obstet Fertil Senol. 2019;47:562\u20137.","journal-title":"Gynecol Obstet Fertil Senol"},{"key":"3129_CR28","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.3109\/14767058.2014.962508","volume":"28","author":"TM Adams","year":"2015","unstructured":"Adams TM, Kinzler WL, Chavez MR, Fazzari MJ, Vintzileos AM. Practice patterns in the timing of antenatal corticosteroids for fetal lung maturity. J Matern-Fetal Neonatal Med. 2015;28:1598\u2013601.","journal-title":"J Matern-Fetal Neonatal Med"},{"key":"3129_CR29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ejogrb.2016.09.018","volume":"206","author":"MMC Bruijn","year":"2016","unstructured":"Bruijn MMC, Vis JY, Wilms FF, Oudijk MA, Kwee A, Porath MM, et al. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement. Eur J Obstet Gynecol Reprod Biol. 2016;206:220\u20134.","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-03129-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-020-03129-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-03129-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T23:28:08Z","timestamp":1627946888000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-020-03129-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3129"],"URL":"https:\/\/doi.org\/10.1186\/s12884-020-03129-x","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,3]]},"assertion":[{"value":"28 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The \u201cPatient Protection Committee (CPP) of Paris VIII\u201d approved this protocol on 07\/11\/2017 as reference RC17_0247. The study will be conducted in compliance with the current approved version of the protocol. This research is classified as noninterventional, without additional blood tests or medication. It was a verbal consent from the patients, without written consent, having been approved by the ethics committee. All participants gave their consent. Any change to the protocol document or informed consent form that affects the scientific intent, study design or patient safety or may affect a participant\u2019s willingness to continue participation in the study will be considered a major amendment. All such amendments will be submitted to the \u201cComit\u00e9 de protection des Personnes Paris VIII\u201d for approval. Our study has been listed in the ClinicalTrials database since January 15, 2018, as NCT03401255.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Any authors have financial competing interests. Vincent Dochez is a member of the editorial board (Guillaume Ducarme - Associate Editor) of this journal. The other authors have no non-financial competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"In accordance with legislative provisions (articles L.1121-3 and R.5121-13 of the French Public Health Code), individuals responsible for the quality control of biomedical studies who have access to confidentiality data shall take all necessary precautions to ensure that this confidentiality is maintained, particularly for data pertaining to the intervention, investigational studies, study participants, and results.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"442"}}